114 related articles for article (PubMed ID: 1956045)
1. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
[TBL] [Abstract][Full Text] [Related]
2. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
Raddatz P; Jonczyk A; Schmitges CJ; Sombroek J
Adv Exp Med Biol; 1991; 306():387-90. PubMed ID: 1812733
[No Abstract] [Full Text] [Related]
3. Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites.
Kaltenbronn JS; Hudspeth JP; Lunney EA; Michniewicz BM; Nicolaides ED; Repine JT; RoarK WH; Stier MA; Tinney FJ; Woo PK
J Med Chem; 1990 Feb; 33(2):838-45. PubMed ID: 2405159
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
5. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
[TBL] [Abstract][Full Text] [Related]
6. Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
Raddatz P; Minck KO; Rippmann F; Schmitges CJ
J Med Chem; 1994 Feb; 37(4):486-97. PubMed ID: 8120867
[TBL] [Abstract][Full Text] [Related]
7. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy.
Simoneau B; Lavallée P; Anderson PC; Bailey M; Bantle G; Berthiaume S; Chabot C; Fazal G; Halmos T; Ogilvie WW; Poupart MA; Thavonekham B; Xin Z; Thibeault D; Bolger G; Panzenbeck M; Winquist R; Jung GL
Bioorg Med Chem; 1999 Mar; 7(3):489-508. PubMed ID: 10220035
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
9. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
[TBL] [Abstract][Full Text] [Related]
10. Orally active water-soluble N,O-acyl transfer products of a beta,gamma-bishydroxyl amide containing renin inhibitor.
Hurley TR; Colson CE; Hicks G; Ryan MJ
J Med Chem; 1993 May; 36(10):1496-8. PubMed ID: 8496918
[No Abstract] [Full Text] [Related]
11. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
12. Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2-P3 sites.
Jung GL; Anderson PC; Bailey M; Baillet M; Bantle GW; Berthiaume S; Lavallée P; Llinas-Brunet M; Thavonekham B; Thibeault D; Simoneau B
Bioorg Med Chem; 1998 Dec; 6(12):2317-36. PubMed ID: 9925293
[TBL] [Abstract][Full Text] [Related]
13. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeys.
Thaisrivongs S; Pals DT; DuCharme DW; Turner SR; DeGraaf GL; Lawson JA; Couch SJ; Williams MV
J Med Chem; 1991 Feb; 34(2):633-42. PubMed ID: 1995887
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements.
Kleinert HD; Luly JR; Marcotte PA; Perun TJ; Plattner JJ; Stein H
FEBS Lett; 1988 Mar; 230(1-2):38-42. PubMed ID: 3280345
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
[TBL] [Abstract][Full Text] [Related]
17. Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.
Göschke R; Stutz S; Rasetti V; Cohen NC; Rahuel J; Rigollier P; Baum HP; Forgiarini P; Schnell CR; Wagner T; Gruetter MG; Fuhrer W; Schilling W; Cumin F; Wood JM; Maibaum J
J Med Chem; 2007 Oct; 50(20):4818-31. PubMed ID: 17824679
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
19. Design of rat renin inhibitory peptides.
Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
[TBL] [Abstract][Full Text] [Related]
20. Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.
Maibaum J; Stutz S; Göschke R; Rigollier P; Yamaguchi Y; Cumin F; Rahuel J; Baum HP; Cohen NC; Schnell CR; Fuhrer W; Gruetter MG; Schilling W; Wood JM
J Med Chem; 2007 Oct; 50(20):4832-44. PubMed ID: 17824680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
